When it comes to treating Diabetic Ketoacidosis (DKA) in emergency care, healthcare providers face a unique challenge in billing for the treatments required to stabilize the patient. One common problem? CO-18 denials—and these can severely impact reimbursement for life-saving treatments. In this blog, we’ll explain why CO-18 denials happen, what you can do to prevent them, and how ACP Billing Services can help you resolve these denials so your practice gets paid for the critical care you provide.
What is CO-18 Denial Code?
The CO-18 denial code occurs when a claim is rejected due to duplicate billing. Essentially, this denial means that the insurance company believes the same service has been billed more than once for the same patient, usually for repeated treatments or lab tests that were done during the same episode of care.
When treating Diabetic Ketoacidosis (DKA)—a potentially life-threatening complication of diabetes that requires immediate medical intervention, such as insulin administration, intravenous fluids, and electrolyte balance management—duplicate billing mistakes are common in busy emergency departments or urgent care settings.
If your practice has encountered CO-18 denials for DKA treatment, don’t worry. With the right approach, you can fix the issue and get your claims approved.
Why Does CO-18 Denial Happen for DKA Treatment?
Here’s why CO-18 denials are common for DKA treatment:
- Duplicate Submissions: The most common reason for CO-18 is that the same treatment or service (e.g., lab tests, insulin administration) has been billed multiple times. In high-pressure environments like the ER, it’s easy to submit the same service by mistake.
- Incorrect Coding: Sometimes, coding errors can result in duplicate claims. If your office mistakenly submits multiple codes for the same treatment, insurance companies may flag it as duplicate billing.
- Multiple Providers Involved: If different doctors or specialists are treating the patient, it’s important to ensure that only one claim for the service is submitted per patient encounter.
How to Prevent and Overcome CO-18 Denials for DKA Treatment
Here’s how you can reduce the likelihood of CO-18 denials for DKA treatment and what you should do if you encounter one:
1. Review and Verify Claims Before Submission
The first step in avoiding duplicate billing is to verify claims before submission. Ensure that each procedure and treatment is billed correctly and only once. Double-check your codes and confirm that you’re not submitting the same service multiple times.
- Action: Have a team member double-check all claims for duplicate submissions before they are submitted to the insurance company. Consider using billing software to automatically detect duplicate codes.
2. Properly Document All Treatments and Procedures
Thorough documentation is key to preventing duplicate billing. Make sure to document every step of the DKA treatment, including each test, medication, and procedure provided.
- Action: Include detailed clinical notes, lab results, and treatment logs that clearly indicate what services were rendered and when.
3. Use Correct and Specific ICD-10 and CPT Codes
Accurate coding is crucial for ensuring that your claims are processed correctly. Using the right ICD-10 codes and CPT codes for DKA treatment helps prevent the claim from being flagged as duplicate.
- Action: Use the appropriate ICD-10 code (e.g., E10.10 / E11.10 – Diabetic Ketoacidosis) and corresponding CPT codes for each procedure performed. Ensure no unnecessary services are included in the claim.
4. Conduct Regular Internal Audits
Regular audits of your billing processes can help detect potential duplicate billing errors before they become a problem. Routine audits ensure that claims are accurate and compliant.
- Action: Implement a process where claims are reviewed by a billing supervisor to catch duplicate submissions and other common mistakes.
5. Appeal the Denial with Supporting Documentation
If your claim is denied under CO-18, don’t panic. Submit an appeal with supporting documentation, including treatment logs, test results, and proof that the services were not duplicated.
- Action: Submit an appeal with additional clinical notes that explain why the treatments provided were medically necessary and performed at separate times.
How ACP Billing Services Can Help
Dealing with CO-18 denials can be frustrating, but with the help of ACP Billing Services, you can ensure that your claims are accurately processed and reimbursed. With our expertise in medical billing and denial management, we can help:
- Review and verify your claims for accuracy
- Ensure proper documentation and coding
- Appeal denials with the appropriate supporting documentation
- Streamline your entire billing process to avoid future denials
Conclusion
Don’t let CO-18 denials for DKA treatment hinder your practice’s ability to get paid for critical care. By verifying claims, ensuring correct documentation, and working with ACP Billing Services, you can minimize the chances of duplicate billing and ensure proper reimbursement. If you’re struggling with denial management or need help with medical billing, contact ACP Billing Services today and let us help you resolve these issues.
Don’t let inefficient billing practices hold you back. Take the first step toward improving your practice’s financial health today with ACP Billing Services.
Want to learn more? Let’s discuss your needs on a quick call. Book your appointment now!
Stay updated with the latest news and industry insights — follow us on our social media channels!